Abstract
Noninvasive treatments to treat the brain-related disorders have been paying more significant attention and it is an emerging topic. However, overcoming the blood brain barrier (BBB) is a key obstacle to most of the therapeutic drugs to enter into the brain tissue, which significantly results in lower accumulation of therapeutic drugs in the brain. Thus, administering the large quantity/doses of drugs raises more concerns of adverse side effects. Nanoparticle (NP)-mediated drug delivery systems are seen as potential means of enhancing drug transport across the BBB and to targeted brain tissue. These systems offer more accumulation of therapeutic drugs at the tumor site and prolong circulation time in the blood. In this review, we summarize the current knowledge and advancements on various nanoplatforms (NF) and discusses the use of nanoparticles for successful cross of BBB to treat the brain-related disorders such as brain tumors, Alzheimer’s disease, Parkinson’s disease, and stroke.
| Original language | English |
|---|---|
| Article number | 3055 |
| Pages (from-to) | 1-23 |
| Number of pages | 23 |
| Journal | Polymers |
| Volume | 12 |
| Issue number | 12 |
| DOIs | |
| State | Published - 12 2020 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Alzheimer’s disease
- Blood brain barrier
- Brain tumor
- Nanoparticle
- Parkinson’s disease
- Stroke
Fingerprint
Dive into the research topics of 'Advancements in the blood–brain barrier penetrating nanoplatforms for brain related disease diagnostics and therapeutic applications'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver